Major bleeding | | 33.68 (1.56 to 719.74) | 0.02 |
Age >70 years | | 12.09 (1.77 to 82.73) | 0.01 |
Use of glycoprotein IIb/IIIa inhibitors | | 11.20 (2.31 to 54.42) | 0.003 |
ST-segment elevated myocardial infarction | | 9.72 (1.21 to 78.36) | 0.03 |
Active smoking | | 8.54 (1.37 to 53.30) | 0.02 |
Carotid artery disease | | 7.15 (1.22 to 41.90) | <0.03 |
Female gender | | 6.54 (1.47 to 29.19) | 0.01 |
Radial access | | 0.06 (0.01 to 0.41) | 0.004 |
Previous stroke | | 3.19 (0.39 to 26.21) | 0.28 |
Procedure duration >45 minutes | | 2.32 (0.55 to 9.67) | 0.25 |
Cardiogenic shock at presentation | | 2.31 (0.05 to 103.89) | 0.67 |
Chronic renal failure | | 1.67 (0.24 to 11.63) | 0.60 |
Acute coronary syndrome | | 1.41 (0.21 to 78.36) | 0.72 |
Obstructive peripheral artery disease | | 0.48 (0.06 to 3.91) | 0.49 |
Chronic stable angina | | 0.29 (0.01 to 5.55) | 0.41 |